In cerebrospinal fluid ER chaperones ERp57 and calreticulin bind β-amyloid

Biochemical and Biophysical Research Communications

Volumn 332, Issue 1, 2005, Pages 50-57

  Erickson, Richard R ^a   Dunning, Lisa M ^a   Olson, Douglas A ^c   Cohen, Sheftel J ^a,d   Davis, Alan T ^d   Wood, W Gibson ^a,d   Kratzke, Robert A ^a,d   Holtzman, Jordan L ^a,b,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Regions Medical Center   (United States)

^d VA MEDICAL CENTER   (United States)

Author keywords

Amyloids; Alzheimer's disease; Calreticulin; Dementia; ERp57; Posttranslational protein processing

Indexed keywords

AMYLOID BETA PROTEIN; CALRETICULIN; CARRIER PROTEIN; CHAPERONE; PROTEIN P57;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COMPLEX FORMATION; ENDOPLASMIC RETICULUM; HUMAN; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

AGING; AMYLOID BETA-PROTEIN; CALRETICULIN; ENDOPLASMIC RETICULUM; HEAT-SHOCK PROTEINS; HUMANS; ISOMERASES; MOLECULAR CHAPERONES; PROTEIN BINDING; PROTEIN DISULFIDE-ISOMERASE;

EID: 19344365444     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.090     Document Type: Article

References (46)

1. N.A. Avdulov, S.V. Chochina, U. Igbavboa, C.S. Warden, A.V. Vassiliev, and W.G. Wood Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids J. Neurochem. 69 1997 1746 1752
2. C.L. Lendon, F. Ashall, and A.M. Goate Exploring the etiology of Alzheimer disease using molecular genetics J. Am. Med. Assoc. 277 1997 825 831
3. T. Pirttila, K.S. Kim, P.D. Mehta, H. Frey, and H.M. Wisniewski Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls J. Neurol. Sci. 127 1994 90 95
4. D.J. Selkoe Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399 Suppl. 24 1999 A23 A31
5. R. Orlando, P.T. Kenny, and M.G. Zagorski Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutions Biochem. Biophys. Res. Commun. 184 1992 686 691
6. N. Ida, T. Hartmann, J. Pantel, J. Schroder, R. Zerfass, H. Forstl, R. Sandbrink, C.L. Masters, and K. Beyreuther Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay J. Biol. Chem. 271 1996 22908 22914
7. R.M. Nitsch, G.W. Rebeck, M. Deng, U.I. Richardson, M. Tennis, D.B. Schenk, C. Vigo-Pelfrey, I. Lieberburg, R.J. Wurtman, B.T. Hyman, and J.H. Growdon Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype Ann. Neurol. 37 1995 512 518
8. T. Pirttila, K.S. Kim, P.D. Mehta, H. Frey, and H.M. Wisniewski Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain Arch. Neurol. 53 1996 189 193
9. A. Tamaoka, N. Sawamura, T. Fukushima, S. Shoji, E. Matsubara, M. Shoji, S. Hirai, Y. Furiya, R. Endoh, and H. Mori Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease J. Neurol. Sci. 148 1997 41 45
10. R. Mayeux, Y. Stern, R. Ottman, T.K. Tatemichi, M.X. Tang, G. Maestre, C. Ngai, B. Tycko, and H. Ginsberg Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease N. Engl. J. Med. 338 1993 506 511
11. R.D. Moir, C.S. Atwood, D.M. Romano, M.H. Laurans, X. Huang, A.I. Bush, J.D. Smith, and R.E. Tanzi Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations Biochemistry 38 1999 4595 4603
12. J. Ghiso, E. Matsubara, A. Koudinov, N.H. Choi-Miura, M. Tomita, T. Wisniewski, and B. Frangione The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex Biochem. J. 293 1993 27 30
13. A.R. Koudinov, N.V. Koudinova, A. Kumar, R.C. Beavis, and J. Ghiso Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins Biochem. Biophys. Res. Commun. 223 1996 592 597
14. J.L. Holtzman The physiological roles of the thiol:protein disulfide oxidoreductases N. Guzman Prolyl-4-hydroxylase protein disulfide isomerase and other structurally related proteins 1998 Marcel Dekker New York 173 236
15. R.A. Berg, N.L. Kedersha, and N.A. Guzman Purification and partial characterization of the two nonidentical subunits of prolyl hydroxylase J. Biol. Chem. 254 1979 3111
16. J. Koivu, and R. Myllyla Protein disulfide-isomerase retains procollagen prolyl 4-hydroxylase structure in its native conformation Biochemistry 25 1986 5982 5986
17. N.-Q. Chen, A.T. Davis, E.C. Canbulat, Y.-X. Liu, S. Goueli, B.A. McKenzie, E.D. Eccleston Jr., K. Ahmed, and J.L. Holtzman Evidence that casein kinase 2 phosphorylates hepatic, microsomal, calcium binding proteins 1 and 2 (ERp72) but not 3 (calreticulin) Biochemistry 25 1996 8299 8306
18. C. Haass, E.H. Koo, A. Mellon, A.Y. Hung, and D.J. Selkoe Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments Nature 357 1992 500 503
19. S.P. Srivastava, N.-Q. Chen, Y.-X. Liu, and J.L. Holtzman Purification and characterization of a new isozyme of thiol:protein disulfide oxidoreductase from rat hepatic microsomes: relationship of this isozyme to cytosolic phosphatidylinositol specific phospholipase C form 1A J. Biol. Chem. 266 1991 20337 20344
20. J.G. Elliott, J.D. Oliver, and S. High The thiol-dependent reductase ERp57 interacts specifically with N-glycosylated integral membrane proteins J. Biol. Chem. 272 1997 13849 13855
21. J.D. Oliver, F.J. van der Wal, N.J. Bulleid, and S. High Interaction of the thiol dependent reductase ERp57 with nascent glycoproteins Science 275 1997 86 88
22. L. Ellgaard, and A. Helenius ER quality control: towards an understanding at the molecular level Curr. Opin. Cell Biol. 13 2001 431 437
23. E.M. Frickel, R. Riek, I. Jelesarov, A. Helenius, K. Wuthrich, and L. Ellgaard TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain Proc. Natl. Acad. Sci. USA 99 2002 1954 1959
24. C.L. Masters, G. Simms, N.A. Weinman, G. Multhaup, B.L. McDonald, and K. Beyreuther Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. USA 82 1985 4245 4249
25. D.L. Miller, I.A. Papayannopoulos, J. Styles, S.A. Bobin, Y.Y. Lin, K. Biemann, and K. Iqbal Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease Arch. Biochem. Biophys. 301 1993 41f 52f
26. H. Mori, K. Takio, M. Ogawara, and D.J. Selkoe Mass spectrometry of purified amyloid beta protein in Alzheimer's disease J. Biol. Chem. 267 1992 17082 17086
27. P. Seubert, T. Oltersdorf, M.G. Lee, R. Barbour, C. Blomquist, D.L. Davis, K. Bryant, L.C. Fritz, D. Galasko, L.J. Thal, I. Lieberburg, and D.B. Schenk Secretion of bamyloid precursor protein cleaved at the amino terminus of the bamyloid peptide Nature 361 1993 260 263
28. A. Golabek, M.A. Marques, M. Lalowski, and T. Wisniewski Amyloid binding proteins in vitro and in normal human cerebrospinal fluid Neurosci. Lett. 191 1995 79 82
29. M.P. McDonald, J.B. Overmier, S. Bandyopadhyay, D. Babcock, and J. Cleary Reversal of beta-amyloid-induced retention deficit after exposure to training and state cues Neurobiol. Learn. Mem. 65 1996 35 47
30. E. O'Hare, D.T. Weldon, P.W. Mantyh, J.R. Ghilardi, M.P. Finke, M.A. Kuskowski, J.E. Maggio, R.A. Shephard, and J. Cleary Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42) Brain Res. 815 1999 1 10
31. P. Giannakopoulos, P.R. Hof, J.P. Michel, J. Guimon, and C. Bouras Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts Brain Res. Brain Res. Rev. 25 1997 217 245
32. R. Katzman, R. Terry, R. DeTeresa, T. Brown, P. Davies, P. Fuld, X. Renbing, and A. Peck Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques Ann. Neurol. 23 1988 138 144
33. D.S. Wolf, M. Gearing, D.A. Snowdon, H. Mori, W.R. Markesbery, and S.S. Mirra Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study Alzheimer Dis. Assoc. Disord. 13 1999 226 231
34. L.M. Callahan, W.A. Vaules, and P.D. Coleman Progressive reduction of synaptophysin message in single neurons in Alzheimer disease J. Neuropathol. Exp. Neurol. 61 2002 384 395
35. T.E. Oddo, A. Caccamo, J.D. Shepard, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaPerta Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Ab and synaptic dysfunction Neuron 39 2004 409 421
36. C.I. Sze, J.C. Troncoso, C. Kawas, P. Mouton, D.L. Price, and L.J. Martin Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease J. Neuropathol. Exp. Neurol. 56 1997 933 944
37. A.A. McCracken, and J.L. Brodsky Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation ERAD Bioessays 25 2003 868 877
38. M. Calfon, H.Q. Zeng, F. Urano, J.H. Till, S.R. Hubbard, H.P. Harding, S.G. Clark, and D. Ron IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA Nature 415 2002 92 96
39. J. Fernandez, I. Yaman, P. Sarnow, M.D. Snider, and M. Hatzoglou Regulation of internal ribosomal entry site-mediated translation by phosphorylation of the translation initiation factor eIF2 alpha J. Biol. Chem. 277 2002 19198 19205
40. H.P. Harding, H.Q. Zeng, Y.H. Zhang, R. Jungries, P. Chung, H. Plesken, D.D. Sabatini, and D. Ron Diabetes mellitus and exocrine pancreatic dysfunction in Perk-/- mice reveals a role for translational control in secretory cell survival Mol. Cell 7 2001 1153 1163
41. Y.J. Ma, J.W. Brewer, J.A. Diehl, and L.M. Hendershot Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response J. Mol. Biol. 318 2002 1351 1365
42. K. Zhang, and R.J. Kaufman Signaling the unfolded protein response from the endoplasmic reticulum J. Biol. Chem. 279 2004 25935 25938
43. T.A. Rapoport Protein transport across the endoplasmic reticulum membrane: facts, models and mysteries FASEB J. 5 1991 2792 2798
44. T. Suzuki, Q. Yan, and W.J. Lennarz Complex, two-way traffic of molecules across the membrane of the endoplasmic reticulum J. Biol. Chem. 273 1998 10083 10086
45. D.M. Walsh, B.P. Tseng, R.E. Rydel, M.B. Podlisny, and D.J. Selkoe The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain Biochemistry 39 2000 10831 10839
46. N.G. Haigh, and A.E. Johnson A new role for BiP: closing the aqueous translocon pore during protein integration into the ER membrane J. Cell Biol. 156 2002 261 270